U.S. markets open in 6 hours 17 minutes
  • S&P Futures

    4,253.50
    +7.75 (+0.18%)
     
  • Dow Futures

    34,525.00
    +63.00 (+0.18%)
     
  • Nasdaq Futures

    14,029.50
    +35.25 (+0.25%)
     
  • Russell 2000 Futures

    2,334.70
    +4.20 (+0.18%)
     
  • Crude Oil

    71.36
    +0.45 (+0.63%)
     
  • Gold

    1,863.10
    -16.50 (-0.88%)
     
  • Silver

    27.94
    -0.20 (-0.71%)
     
  • EUR/USD

    1.2099
    -0.0007 (-0.06%)
     
  • 10-Yr Bond

    1.4620
    0.0000 (0.00%)
     
  • Vix

    15.65
    -0.45 (-2.80%)
     
  • GBP/USD

    1.4096
    -0.0021 (-0.15%)
     
  • USD/JPY

    109.6750
    +0.0400 (+0.04%)
     
  • BTC-USD

    39,543.12
    +4,248.69 (+12.04%)
     
  • CMC Crypto 200

    985.58
    +43.77 (+4.65%)
     
  • FTSE 100

    7,134.06
    0.00 (0.00%)
     
  • Nikkei 225

    29,161.80
    +213.07 (+0.74%)
     

Comerica Incorporated Just Beat EPS By 286%: Here's What Analysts Think Will Happen Next

  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
  • Oops!
    Something went wrong.
    Please try again later.

As you might know, Comerica Incorporated (NYSE:CMA) just kicked off its latest quarterly results with some very strong numbers. The company beat both earnings and revenue forecasts, with revenue of US$718m, some 2.5% above estimates, and statutory earnings per share (EPS) coming in at US$0.80, 286% ahead of expectations. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

See our latest analysis for Comerica

earnings-and-revenue-growth
earnings-and-revenue-growth

Taking into account the latest results, the current consensus from Comerica's 19 analysts is for revenues of US$2.89b in 2020, which would reflect a notable 14% increase on its sales over the past 12 months. Statutory earnings per share are forecast to plunge 56% to US$1.88 in the same period. Before this earnings report, the analysts had been forecasting revenues of US$2.87b and earnings per share (EPS) of US$1.10 in 2020. There was no real change to the revenue estimates, but the analysts do seem more bullish on earnings, given the massive increase in earnings per share expectations following these results.

The consensus price target was unchanged at US$41.14, implying that the improved earnings outlook is not expected to have a long term impact on value creation for shareholders. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. The most optimistic Comerica analyst has a price target of US$68.00 per share, while the most pessimistic values it at US$26.00. So we wouldn't be assigning too much credibility to analyst price targets in this case, because there are clearly some widely different views on what kind of performance this business can generate. As a result it might not be a great idea to make decisions based on the consensus price target, which is after all just an average of this wide range of estimates.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. It's clear from the latest estimates that Comerica's rate of growth is expected to accelerate meaningfully, with the forecast 14% revenue growth noticeably faster than its historical growth of 4.9%p.a. over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 2.0% per year. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Comerica to grow faster than the wider industry.

The Bottom Line

The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Comerica following these results. Fortunately, they also reconfirmed their revenue numbers, suggesting sales are tracking in line with expectations - and our data suggests that revenues are expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. At Simply Wall St, we have a full range of analyst estimates for Comerica going out to 2022, and you can see them free on our platform here..

Even so, be aware that Comerica is showing 2 warning signs in our investment analysis , you should know about...

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.